Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-05 Sale |
2024-02-05 6:11 pm |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
36,248 | $2.2209 | $80,503 | 2,731,624 (Direct) |
View |
| 2023-11-20 Purchase |
2023-11-22 5:09 pm |
Verona Pharma plc | VRNA | Edwards Martin Director |
33,736 | $1.837 | $61,973 | 144,800 (Direct) |
View |
| 2023-11-06 Purchase |
2023-11-08 4:15 pm |
Verona Pharma plc | VRNA | EBSWORTH DAVID R Director |
160,000 | $1.9755 | $316,080 | 844,643 (Direct) |
View |
| 2023-11-03 Sale |
2023-11-03 8:11 pm |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
58,752 | $1.92 | $112,804 | 2,840,640 (Direct) |
View |
| 2023-08-03 Sale |
2023-08-07 9:19 pm |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
80,144 | $2.5276 | $202,576 | 2,872,528 (Direct) |
View |
| 2023-08-03 Sale |
2023-08-07 9:17 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
275,888 | $2.5151 | $693,897 | 16,431,800 (Direct) |
View |
| 2023-08-03 Sale |
2023-08-07 9:17 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
275,888 | $2.5151 | $693,897 | 15,521,248 (Direct) |
View |
| 2023-08-03 Sale |
2023-08-07 9:15 pm |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
48,472 | $2.5151 | $121,914 | 2,681,623 (Indirect Direct) |
View |
| 2023-08-01 Sale |
2023-08-03 8:31 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
179,648 | $2.6437 | $474,938 | 15,797,136 (Direct) |
View |
| 2023-08-01 Sale |
2023-08-03 8:30 pm |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
31,552 | $2.6437 | $83,415 | 2,730,095 (Indirect Direct) |
View |
| 2023-08-01 Sale |
2023-08-03 8:29 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
179,648 | $2.6437 | $474,938 | 16,707,688 (Direct) |
View |
| 2023-08-01 Sale |
2023-08-03 8:27 pm |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
33,464 | $2.6437 | $88,469 | 2,952,672 (Direct) |
View |
| 2023-05-11 Sale |
2023-05-15 6:07 pm |
Verona Pharma plc | VRNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director |
482,913 | $20.58 | $9,938,132 | 3,777,778 (Indirect) |
View |
| 2023-05-11 Sale |
2023-05-15 6:06 pm |
Verona Pharma plc | VRNA | Gupta Rishi Director |
482,913 | $20.58 | $9,938,132 | 3,777,778 (Indirect) |
View |
| 2023-05-01 Sale |
2023-05-03 7:49 pm |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
80,376 | $2.5759 | $207,041 | 2,753,319 (Indirect Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 7:49 pm |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
106,176 | $2.5964 | $275,678 | 2,971,136 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 7:48 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
455,528 | $2.5759 | $1,173,395 | 15,976,784 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 7:46 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
455,536 | $2.5759 | $1,173,415 | 16,887,336 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-01 Tax Withholding |
2024-02-05 6:11 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
480,200 | $2.2938 | 15,942,592 (Direct) |
View |
| 2024-02-01 Tax Withholding |
2024-02-05 6:11 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
72,768 | $2.2938 | 2,731,624 (Direct) |
View |
| 2024-02-01 Gift |
2024-02-05 6:10 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
116,592 | $0 | 2,800,407 (Direct) |
View |
| 2024-02-01 Tax Withholding |
2024-02-05 6:10 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
103,408 | $2.2938 | 2,800,407 (Direct) |
View |
| 2024-02-01 Tax Withholding |
2024-02-05 6:09 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
480,664 | $2.2938 | 15,031,576 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 06:07 am |
N/A 2034-01-31 |
Verona Pharma plc | VRNA | Austwick Michael Director |
144,000 | $0 | 144,000 (Direct) |
View |
| 2023-11-01 Tax Withholding |
2023-11-03 8:11 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
173,136 | $1.7438 | 2,840,640 (Direct) |
View |
| 2023-11-01 Tax Withholding |
2023-11-03 8:09 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
173,904 | $1.7438 | 2,707,719 (Direct) |
View |
| 2023-11-01 Gift |
2023-11-03 8:09 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
196,096 | $0 | 2,707,719 (Direct) |
View |
| 2023-11-01 Tax Withholding |
2023-11-03 8:09 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
809,008 | $1.7438 | 16,422,792 (Direct) |
View |
| 2023-11-01 Tax Withholding |
2023-11-03 8:08 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
809,008 | $1.7438 | 15,512,240 (Direct) |
View |
| 2023-10-20 Option Award |
2023-10-24 4:06 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
800,000 | $0 | 17,231,800 (Direct) |
View |
| 2023-10-20 Option Award |
2023-10-24 4:06 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
200,000 | $0 | 3,072,528 (Direct) |
View |
| 2023-10-20 Option Award |
2023-10-24 4:06 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
200,000 | $0 | 2,881,623 (Direct) |
View |
| 2023-10-20 Option Award |
2023-10-24 4:05 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
800,000 | $0 | 16,321,248 (Direct) |
View |
| 2023-09-01 Option Award |
2023-09-05 4:05 pm |
N/A 2033-08-31 |
Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director |
144,000 | $0 | 144,000 (Direct) |
View |
| 2023-08-07 Gift |
2023-08-07 9:15 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
89,976 | $0 | 2,681,623 (Direct) |
View |
| 2023-05-01 Exercise(A) |
2023-05-11 4:16 pm |
N/A 2029-03-29 |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
8,328 | $0 | 1,987,391 (Direct) |
View |
| 2023-05-01 Exercise(A) |
2023-05-11 4:15 pm |
N/A 2029-03-29 |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
15,000 | $0 | 2,986,136 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:24 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | Deschamps Lisa Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:23 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | Ullman Anders Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:23 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | SHAH MAHENDRA Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:23 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | EBSWORTH DAVID R Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:22 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | Edwards Martin Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:20 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | Gupta Rishi Director |
96,000 | $0 | 96,000 (Direct) |
View |